A natural adjacency
PRP for hair uses platelet-rich plasma from the patient's own blood toward hair-restoration goals, typically as a series. For a practice already delivering PRP, it extends an existing capability into a hair-focused service — a relatively natural addition that meets a rising request, often as a recurring series that supports an ongoing patient relationship. That recurring, series-based nature makes it a relationship-building service, not a one-off.
The seriousness it requires
The key owner consideration is that "extending an existing capability" must not become "treating it casually." As a blood-derived treatment, it requires proper handling, safety protocols, consent, and honest expectation-setting about a series-based treatment — the same rigor as PRP for skin. The adjacency makes it convenient to add; it doesn't reduce the clinical and safety standards. Set honest expectations about a series and a gradual goal, and handle the blood-derived product properly.
What to do
- Treat PRP hair restoration as a natural, recurring adjacency for practices already offering PRP.
- Apply full handling, safety, and consent rigor, as with any blood-derived treatment.
- Set honest, series-based expectations, with clinical specifics from trained providers.
- Use the recurring nature to build an ongoing relationship.
Frequently asked questions
What is PRP for hair restoration?
It's the use of platelet-rich plasma, derived from the patient's own blood, applied toward hair restoration goals — typically as a series. It extends a practice's existing PRP capability into a hair-focused service. Clinical specifics belong to trained providers; this is general education, not medical advice.
Is hair restoration a good service line to add?
It's a rising request and a natural adjacency for practices already offering PRP, often delivered as a recurring series that supports an ongoing relationship. As with any blood-derived treatment, it requires proper handling, safety, and consent.
What should owners be careful about?
The same seriousness any blood-derived treatment requires — proper handling, safety protocols, consent, and honest expectation-setting about a series-based treatment, rather than treating it casually because it extends an existing capability.